Skip to main content
. 2022 Jul 15;24(5):529–537. doi: 10.1007/s40272-022-00522-1
Pediatric HCV patients with comorbidities such as cancer, epilepsy, hemophilia, thalassemia, and nephrotic syndrome are neglected.
Pediatric HCV infection has an aggressive course due to associated chronic disease or medications received.
Ledipasvir–sofosbuvir fixed-dose combination is safe and effective in this special population.